The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Vasotop 5 mg tablets

Intervet Ireland LimitedVPA10996/138/003

Main Information

Trade NameVasotop 5 mg tablets
Active SubstancesRamipril
Dosage FormTablet
Licence HolderIntervet Ireland Limited
License Holder AddressMagna Drive
Magna Business Park, Citywest Road
Dublin 24
Licence NumberVPA10996/138/003

Group Information

ATC CodeQC09AA05 ramipril
Therapeutic ClassCardiovascular


License statusAuthorised
Licence Issued27/10/2000
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back